MA52938A - Composés inhibiteurs d'oga - Google Patents
Composés inhibiteurs d'ogaInfo
- Publication number
- MA52938A MA52938A MA052938A MA52938A MA52938A MA 52938 A MA52938 A MA 52938A MA 052938 A MA052938 A MA 052938A MA 52938 A MA52938 A MA 52938A MA 52938 A MA52938 A MA 52938A
- Authority
- MA
- Morocco
- Prior art keywords
- inhibitor compounds
- oga inhibitor
- oga
- compounds
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18382450 | 2018-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52938A true MA52938A (fr) | 2021-04-28 |
Family
ID=62784077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052938A MA52938A (fr) | 2018-06-20 | 2019-06-20 | Composés inhibiteurs d'oga |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210300900A1 (fr) |
EP (1) | EP3810595A1 (fr) |
JP (1) | JP2021528412A (fr) |
CN (1) | CN112334462A (fr) |
AU (1) | AU2019291097A1 (fr) |
CA (1) | CA3102903A1 (fr) |
MA (1) | MA52938A (fr) |
WO (1) | WO2019243531A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018154133A1 (fr) * | 2017-02-27 | 2018-08-30 | Janssen Pharmaceutica Nv | Dérivés de [1,2,4]-triazolo [1,5-a]-pyrimidinyle substitués par de la pipéridine, de la morpholine ou de la pipérazine utilisés en tant qu'inhibiteurs d'oga |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2958966C (fr) * | 2014-08-28 | 2020-01-14 | Asceneuron Sa | Amines cycliques substituees comme inhibiteurs de glucosidase |
EP3419971B1 (fr) * | 2016-02-25 | 2022-04-20 | Asceneuron SA | Inhibiteurs de glycosidases |
AU2017287919A1 (en) * | 2016-06-29 | 2019-01-17 | Orion Corporation | Benzodioxane derivatives and their pharmaceutical use |
WO2018109202A1 (fr) * | 2016-12-16 | 2018-06-21 | Janssen Pharmaceutica Nv | Composés inhibiteurs d'oga monocyclique |
-
2019
- 2019-06-20 CN CN201980041380.4A patent/CN112334462A/zh active Pending
- 2019-06-20 AU AU2019291097A patent/AU2019291097A1/en not_active Abandoned
- 2019-06-20 CA CA3102903A patent/CA3102903A1/fr not_active Abandoned
- 2019-06-20 MA MA052938A patent/MA52938A/fr unknown
- 2019-06-20 EP EP19732990.7A patent/EP3810595A1/fr not_active Withdrawn
- 2019-06-20 WO PCT/EP2019/066390 patent/WO2019243531A1/fr unknown
- 2019-06-20 JP JP2020570577A patent/JP2021528412A/ja active Pending
- 2019-06-20 US US17/253,446 patent/US20210300900A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA3102903A1 (fr) | 2019-12-26 |
US20210300900A1 (en) | 2021-09-30 |
EP3810595A1 (fr) | 2021-04-28 |
JP2021528412A (ja) | 2021-10-21 |
AU2019291097A1 (en) | 2020-12-17 |
WO2019243531A1 (fr) | 2019-12-26 |
CN112334462A (zh) | 2021-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52942A (fr) | Composés inhibiteurs d'oga | |
MA52939A (fr) | Composés inhibiteurs d'oga | |
MA47575A (fr) | Composés inhibiteurs d'oga monocyclique | |
MA47576A (fr) | Composés inhibiteurs d'oga bicyclique | |
MA47420A (fr) | Composés inhibiteurs d'oga | |
MA52948A (fr) | Composés | |
MA52486A (fr) | Pyridazinones utilisés en tant qu'inhibiteurs de parp7 | |
MA52489A (fr) | Nouveaux composés | |
MA51669A (fr) | Composés | |
MA51616A (fr) | Inhibiteurs d'adn-pk | |
MA44725A (fr) | Formulations d'un inhibiteur de lsd1 | |
MA52967A (fr) | Composés antagonistes du pcsk9 | |
MA53003A (fr) | Composés | |
MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
UA42295S (uk) | Комп'ютер | |
MA46652A (fr) | Polythérapie pour l'inhibition de c3 | |
MA46242A (fr) | Composés inhibiteurs de bêta-lactamase | |
MA54521A (fr) | Dérivés d'oxopyridine substitués | |
UA42369S (uk) | Комп'ютер | |
MA49006A (fr) | Inhibiteurs d'ip6k | |
DK3737677T3 (da) | Tetrahydroisoquinolinforbindelser | |
MA52935A (fr) | Composés inhibiteurs d'oga | |
DK3840596T3 (da) | Sammensætning | |
MA52936A (fr) | Composés inhibiteurs d'oga | |
MA52937A (fr) | Composés inhibiteurs d'oga |